Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

PHM 521 > Antihypertension Drugs > Flashcards

Antihypertension Drugs Flashcards

1
Q

First line antihypertensives

A

thiazide diuretics, ACEI, ARB, Calcium Channel Blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

diuretics

A

thiazide diuretics, loop diuretics, mineralocorticoid (aldosterone) receptor antagonists, potassium sparing diuretics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

RAAS blockers

A

ACEI, ARB, direct renin inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

direct vasodilators

A

calcium channel blockers, hydralazine, minoxidil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

sympatholytic agents

A

beta blockers, clonidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

thiazide diuretics can lower BP up tp ___ mmHg and can be used as _____

A

thiazide diuretics can lower BP up to 10-15 mmHg and can be used as a monotherapy for mild htn, but is often used in combination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

chlorthalidone

A

hygroton/thalitone is a first line thiazide diuretic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

hydrochlorothiazide;indapamide

A

lozol is a first line thiazide diuretic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

metolazone

A

zaroxolyn is a first line thiazide diuretic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

thiazide diuretic MOA

A

increases na, water and cl excretion by blocking reabsorption in distal convoluted tubule

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

thiazide diuretic contraindications

A

hypersensitivity to sulfonamides (low risk of cross reactivity), anuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

thiazide diuretic adr

A

dizziness, hyperuricemia, hyponatremia, hypokalemia, hypomagnesemia, hypercalcemia, pancreatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

thiazide diuretic key PK/PD parameters

A

secreted by organic acid secretory system in the proximal tubule which completes with secretion of uric acid –> elevates levels of uric acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

thiazide diuretic notes

A

not as effective if CrCl < 30ml/min (chlorthalidone preferred), avoid NSAIDs, avoid in gout, less effective w/ low GFR, take in morning

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

furosemide

A

lasix is a loop diuretic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

loop diuretic moa

A

actively secreted via nonspecific organ acid transport system into the lumen of the thick ascending loop of Henle, decreasing Na absorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

loop diuretic contraindication

A

anuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

loop diuretic adr

A

hyperuricemia, hypokalemia, hypomagnesemia, dizziness, AKI, ototoxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

loop diuretic DDI

A

increased risk of ototoxicity with aminoglycosides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

loop diuretic notes

A

results in most fluid loss, black boxed for profound fluid and electrolyte loss, more potent than thiazides, preferred in patients with HF, consider ethacrynic acid with true sulfa allergy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

PK/PD of furosemide

A

loop diuretic, 40-70% bioavailability, lasts 4-8 hrs, 1-2 hr half life, mainly renal elimination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

PK/PD of torsemide

A

loop diuretic, 90% bioavailability, lasts 8-12 hrs, 3.5 hr half life, mainly hepatic elimination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

PK/PD of bumetanide

A

loop diuretic, 90% oral bioavailability, 3-6 hr duration, ~1 hr half life, half renal and half hepatic elimination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

PK/PD of ethacrynic acid

A

loop diuretic with 100% oral bioavailability, 2-4 hr IV, 12 hr duration orally, 2-4 hr half life, renal elimination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

spironolactone

A

aldactone/carospir is a mineralocorticoid receptor antagonist (MRA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

eplerenone

A

inspra is a mineralocorticoid receptor antagonist (MRA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

mineralocorticoid receptor antagonist (MRA) moa

A

competes with aldosterone for receptor sites in the distal renal tubules increasing na, cl and water excretion whole conserving k and h ions, may block effect of aldosterone on smooth muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

mineralocorticoid receptor antagonist (MRA) contraindications

A

anuria, hyperkalemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

mineralocorticoid receptor antagonist (MRA) adr

A

dehydration, hyponatremia, dizziness, cardiac arrhythmias due to electrolyte abnormalities
spironolactone: gynecomastia, breast tenderness, impotence
eplerenone: increased TG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

mineralocorticoid receptor antagonist (MRA) key PK/PD

A

spironolactone: binds with high affinity to androgen receptor which causes gynecomastia and decreased libido
eplerenone: much greater selectivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

mineralocorticoid receptor antagonist (MRA) DDi

A

eplerenone: strong CYP3A4 inhibitors will increase concentrations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

mineralocorticoid receptor antagonist (MRA) notes

A

minimally efficacious blood pressure control when used as a monotherapy, preferred in aldosteronism and resistant htn, use with thiazide or loop diuretic to combat K loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

triamterene

A

maxzide is a potassium sparing diuretic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

amiloride

A

potassium sparing diuretic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

potassium sparing diuretic moa

A

competitive inhibition of epithelial na channel in collecting duct of nephron to decrease na reabsorption and increase k reabsorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

potassium sparing diuretic contraindications

A

hypersensitivity to sulfonamides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

potassium sparing diuretic adr

A

hyperkalemia, hypotension, dizziness, ha, gout, sjs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

potassium sparing diuretic PK/PD

A

amiloride has a longer duration of action that triamterene (24 > 8)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

potassium sparing diuretic notes

A

almost always in combination tablet to decrease rates of hyperkalemia with thiazide diuretics, avoid if CrCl <45ml/min, can be used with thiazide or loop diuretic to combat K loss

40
Q

lisinopril

A

prinivil/zestril is an ACEI

41
Q

ACEI moa

A

competitive angiotensin converting enzyme inhibitor that prevents stimulation of angiotensin II receptor which is responsible for vasoconstriction

42
Q

ACEI contraindications

A

history of acei induced, hereditary, or idiopathic angioedema, pregnancy

43
Q

ACEI adr

A

hyperkalemia, aki, dizziness, dry cough, angioedema, liver failure

44
Q

ACEI key PK/PD

A

renally eliminated, inhibits breakdown of bradykinin causing dry cough and angioedema

45
Q

ACEI DDI

A

increased risk of hyperkalemia and/or angioedema in combination with other RAAS inhibitors

46
Q

ACEI notes

A

if side effects- try ARB, combinations available (hydrochlorothiazide, ccb), target organ protection, do not use if K about 5mmol/L, do not use other RAAS

47
Q

valsartan

A

Diovan is an ARB

48
Q

ARB moa

A

selective reversible angiotensin II receptor

49
Q

ARB contraindications

50
Q

ARB adr

A

hyperkalemia, AKI, dizziness, angioedema, rhabdomyolysis

51
Q

ARB DDI

A

increased risk of hyperkalemia and/or angioedema in combination with other RAASi

52
Q

ARB notes

A

may use first if trying to prevent side effects like dry cough, combinations available (hydrochlorothiazide, CCB), target organ protection, do not use if K >5mmol/L, no washout period when transitioning, less dry cough /angioedema

53
Q

amlodipine

A

norvasc is a DHP CCB

54
Q

nifedipine

A

procardia is a DHP CCB

55
Q

DHP CCB moa

A

inhibits calcium ions from entering slow channels of vascular smooth muscle- leading to vasodilation

56
Q

DHP CCB adr

A

peripheral and pulmonary edema, hepatotoxicity, thrombocytopenia

57
Q

DHP CCB key PK/PD

A

may cause reflex sympathetic activation –> slight tachycardia and increase in cardiac output
amlodipine may take at least 3 days to 1 week to see full lowering effects

58
Q

DHP CCB ddi

A

major substrate of CYP3A4

59
Q

DHP CCB notes

A

immediate release nifedipine should not be used as it has increased risk for MI and mortality, can take up to one week to see full effect

60
Q

diltiazem

A

cardizem is a NONDHP CCB

61
Q

verapamil

A

calan is a NONDHP CCB

62
Q

NONDHP CCB moa

A

inhibits ca ions from entering smooth muscle and myocardium, causing vasodilation and slowing of AV node

63
Q

NONDHP CCB contraindications

A

2nd or 3rd degree heart block

64
Q

NONDHP CCB adr

A

peripheral edema, pulmonary edema, ha, heart failure, heart block, hepatotoxicity

65
Q

NONDHP CCB key PK/PD

A

verapamil has the greatest depressive effects on SNS

66
Q

NONDHP CCB ddi

A

major substrates of CYP3A4, moderate inhibitors of CYP3A4 - ddi worse with verapamil

67
Q

hydralazine

A

apresoline is a vasodilator

68
Q

hydralazine moa

A

direct vasodilation

69
Q

hydralazine contraindications

A

CAD- causes reflex tachycardia and angina

70
Q

hydralazine adr

A

dizziness, reflex tachycardia, DILE at high doses

71
Q

hydralazine PK/PD

A

variable duration and effect, short half-life that requires frequent dosing

72
Q

hydralazine notes

A

dosing for htn is 4x daily, less reflex tachycardia risk than minoxidil

73
Q

minoxidil moa

A

direct vasodilation

74
Q

minoxidil contraindications

A

CAD- causes reflex tachycardia and angina

75
Q

minoxidil adr

A

dizziness, reflex tachycardia, hypertrichosis, pericarditis

76
Q

minoxidil notes

A

causes fluid and water retention- should be given with a diuretic, should be given with a beta blocker to prevent tachycardia, extremely potent vasodilator, increased risk of reflex tachycardia

77
Q

metoprolol

A

lopressor/toprol is a beta blocker

78
Q

beta blocker moa

A

inhibits beta 1/2 receptors decreasing HR and myocardial contractility- varies based on selectivity

79
Q

beta blocker contraindications

A

severe bradycardia

80
Q

beta blocker adr

A

dizziness, fatigue, reduced exercise tolerance, bronchospasm, insomnia, impotence

81
Q

beta blocker notes

A

avoid abrupt withdrawal, patients may feel fatigued at start- this will abate with time, can mask feelings of low glucose, use with caution in patients with severe bronchospastic disease, can enhance hypoglycemic effects

82
Q

beta blocker ddi

A

additive av nodal blockade with NONDHP CCB

83
Q

beta 1 selective blockers

A

atenolol, betaxolol, bisoprolol, esmolol, metoprolol, nebivolol, acebutolol

84
Q

blockers with beta 1 and 2 activity

A

carvedilol, labetalol, nadolol, pindolol, propranolol, sotalol, timolol

85
Q

beta blockers with alpha 1 blockagte

A

carvedilol, labetalol

86
Q

beta blockers with NO stimulation

87
Q

beta blockers with SNS activity

A

acebutolol, pindolol

88
Q

clonidine

A

catapres/kapvay is an alpha 2 agonist

89
Q

alpha 2 agonist moa

A

stimulates alpha 2 receptors resulting in reduced sympathetic outflow from CNS

90
Q

alpha 2 agonist adr

A

dry mouth, somnolence/fatigue/sedation, constipation, clonidine patch may have local irritation as well

91
Q

alpha 2 agonist PK/PD

A

lipid soluble, short half-life- dosed at least 2x daily

92
Q

alpha 2 agonist notes

A

avoid abrupt discontinuation, use patch for 7 days- takes 2-3 days onset- oral dosing needed at that time

93
Q

NON DHP CCB notes

A

cyp3a4 major substrate inhibitor (dose adjustments for lovastatin/simvastatin), avoid in patients w HFrEF, avoid routine use with beta blockers, multiple brands exist, diltiazem is the only brand w capsules that can be sprinkled over food

94
Q

aliskiren

A

tekturna is a direct renin inhibitor
should not be used with other RAAS, long half life, lack of data, expensive

95
Q

doxazosin

A

cardura is an alpha 1 agonist can treat htn and bph in men, increase risk of hf and orthostatic hypotension

PHM 521 (11 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions